LncRNA-CDKN2B (cyclin-dependent kinase inhibitor 2B) expression is upregulated and changes the chromatin structure by recruiting chromatin modification factors to regulate the expression of target genes, ultimately promoting the proliferation of HCC cells (40). Here, CDKN2B is linked to hepatocellular carcinoma.